Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition.

Wei, Xi; Li, Qing; Li, Ying; Duan, Wei; Huang, Chongbiao; Zheng, Xiangqian; Sun, Lei; Luo, Jingtao; Wang, Dong; Zhang, Sheng; Xin, Xiaojie; Gao, Ming

Wei, Xi; Li, Qing; Li, Ying; Duan, Wei; Huang, Chongbiao; Zheng, Xiangqian; Sun, Lei; Luo, Jingtao; Wang, Dong; Zhang, Sheng; Xin, Xiaojie; Gao, Ming.

Afiliação

Wei X; Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Li Q; These authors contributed equally to this work.
Li Y; Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.
Duan W; These authors contributed equally to this work.
Huang C; The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Zheng X; These authors contributed equally to this work.
Sun L; Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.
Luo J; Department of Senior Ward, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Wang D; Department of Thyroid and Cervical Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Zhang S; Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Xin X; The Department of Otorhinolaryngology and Maxillofacial Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute, National Clinical Research Center of Cancer, Tianjin, China.
Gao M; Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China.

Oncotarget ; 13: 118-119, 2022.

Article em En | MEDLINE | ID: mdl-35035777

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google